You are CSO at a $600M industrial-tech manufacturer — Board prep, Friday. CEO asks: "A competitor just filed a major patent in our core white-space, and a senior engineer of theirs just resigned. Should we acqui-hire, accelerate our own roadmap, or pivot the H2 plan?"
Acqui-hire, accelerate, or pivot H2 — what's the optimal play?
Mesh composite answer
Recommended play: Acqui-hire S. Chen + accelerate Path-3 prototype + file 4 defensive continuations within 60 days.
PatentPulse confirms the competitor filing has 0.72 overlap with your white-space and blocks 2 of 3 development paths. But two prior-art anchors (a 1996 paper + a 2018 patent) materially weaken claims 1, 4, and 7 — your IP team can challenge those. Path-3 (the unblocked path) is technically harder but TalentIntel surfaces the inventor (S. Chen, 11.4y, currently signaling open to work) — acqui-hiring her transfers the institutional know-how at lower cost than a 4-quarter R&D catch-up. SentimentDNA + EarningsIntel show the competitor is over-extending (+38% capex, hiring slowdown), giving you a 6-9 month window before they consolidate. Optimal play: hire Chen ($600-800K all-in), file 4 defensive continuations on Path-3 in the next 60 days, and re-run this mesh quarterly.
This is a recorded demo. Numbers shown are synthetic and illustrative —
designed to show how the mesh fuses signals across flagships. The free trial runs the
same workflow on your own data with live FXWatch / SentimentDNA / CreditPulse / etc.
feeds. No live Claude calls were made on this page.